SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
________
FORM 10-QA
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE
ACT OF 1934
For the quarterly period ended May 25, 1996
------------
or
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
Commission file number 0-12991
-------
THE LANGER BIOMECHANICS GROUP, INC.
-----------------------------------
(Exact name of registrant as specified in its charter.)
NEW YORK 11-2239561
------------------------------- -----------------------
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization.) Identification No.)
450 COMMACK ROAD, DEER PARK, NY 11729
---------------------------------------------------------
Address of principal executive offices) (Zip Code)
(516) 667-1200
---------------------------------------------------------
(Registrant's telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.
YES X NO
----- ----
Indicate the number of shares outstanding of each of the issuer's classes
of common stock, as of the latest practical date.
Common Stock, $.02 Par Value -- 2,584,281 shares as of July 22, 1996.
<PAGE>
SIGNATURES
PURSUANT TO THE REQUIREMENTS OF THE SECURITIES EXCHANGE ACT OF 1934, THE
REGISTRANT HAS DULY CAUSED THIS REPORT TO BE SIGNED ON ITS BEHALF BY THE
UNDERSIGNED THEREUNTO DULY AUTHORIZED.
THE LANGER BIOMECHANICS GROUP, INC.
___________________________________
(REGISTRANT)
DATE: JULY 22, 1996
BY: /s/ GARY L. GRAHN
--------------------
GARY L. GRAHN
PRESIDENT AND CHIEF EXECUTIVE OFFICER
BY: /s/ DONALD M. CARBONE
----------------------
DONALD M. CARBONE
VICE PRESIDENT - FINANCE AND
CHIEF FINANCIAL OFFICER
(PRINCIPAL FINANCIAL OFFICER)
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THE LANGER BIOMECHANICS GROUP, INC.
AND SUBSIDIARIES
Financial Statement Schedule
For The Three Months Ended: May 25, 1996
</LEGEND>
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> DEC-31-1996
<PERIOD-END> DEC-31-1996
<CASH> 700,237
<SECURITIES> 0
<RECEIVABLES> 1,578,576
<ALLOWANCES> 15,000
<INVENTORY> 804,207
<CURRENT-ASSETS> 3,357,268
<PP&E> 2,606,549
<DEPRECIATION> 2,005,668
<TOTAL-ASSETS> 4,146,134
<CURRENT-LIABILITIES> 1,706,978
<BONDS> 0
0
0
<COMMON> 51,627
<OTHER-SE> 1,947,980
<TOTAL-LIABILITY-AND-EQUITY> 4,146,134
<SALES> 2,512,567
<TOTAL-REVENUES> 2,512,567
<CGS> 1,471,300
<TOTAL-COSTS> 1,471,300
<OTHER-EXPENSES> 1,025,836
<LOSS-PROVISION> 3,805
<INTEREST-EXPENSE> 3,089
<INCOME-PRETAX> 27,357
<INCOME-TAX> 3,419
<INCOME-CONTINUING> 23,938
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 23,938
<EPS-PRIMARY> 0.01
<EPS-DILUTED> 0
</TABLE>
